EXAMINATION DATE: |
10/16/2000 |
|
STEVE PERKINS MD
5939 HARRY HINES BLDG. 2
SUITE
DALLAS, TX 75235 |
| PATIENT: |
FURLONG,
NEILA |
ACCOUNT#: 107501 |
DOB: 1941-06-01
EXAM: M
R I BRAIN W & W/O CONTRAST |
TECHNIQUE:
This 184-slice MRI scan of the
brain was performed in the following sequences:
Pre-Contrast
1. Sagittal T1-weighted 5mm
thickness.
2. Axial T1-weighted 5 mm
thickness.
3. Axial T2-weighted 5 mm
thickness.
4. Axial FLAIR 5 mm
thickness.
5. Coronal FLAIR 5 mm
thickness.
Post-Constrast:
1. Axial T1-weighted 5 mm
thickness.
2. Coronal t1-weighted 5 mm thickness.
|
FINDINGS:
There are extensive coalescent
areas of increased signal on T1 and T2-weighted images in the periventricular
white matter and centrum semiovale occupying almost the entirety of the white
matter tracts. There are also small and
punctate
areas of increased signal in the basal ganglia, thalamic nuclei and midbrain.
The ventricles and cisternal spaces are prominent and compatible with
cerebral atrophy. There are no areas of abnormal enhancement to suggest
active metastatic disease. The above is nonspecific but most compatible
with post radiation
gliosis.
The bony clavarium and skull bse is intact.
|
IMPRESSION:
1. Extensive
gliosis
in the periventricular white matter, with cerebral atrophy. There are
also abnormal areas of increased signal in the basal ganglia, thalamic nuclei
and midbrain. Given prior history of metastatic disease to the brain and
radiation therapy, this likely is secondary to radiation and/or
chemotherapeutic gliosis. Lact of contrast enhancement mitigates against
active metastasis. |
STEVEN STEINBAUM,
M.D.
Neuroradiologist
SS:jlg
D: 10/16/00
T:
10/16/00
PATIENT: FURLONG, NEILA
| PATIENT: |
FURLONG,
NEILA |
ACCOUNT#: 107501 |
Page 2 of 2
|
